Panagora Asset Management’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
N
Panagora Asset Management's FLNA Position: Q3 2021 in Review
Panagora Asset Management sold out of Filana Therapeutics (FLNA) in Q3 2021, closing a stake of 3,562 shares — an estimated $304K sold.
Panagora Asset Management first reported a position in FLNA in Q1 2014 and held it in 14 quarters. The position peaked at $427K in Q2 2014. 180 funds tracked by Wall St. Rank hold FLNA as of Q3 2021.
- Panagora Asset Management reported no remaining Filana Therapeutics position as of Q3 2021 after selling out during the quarter.
- Panagora Asset Management sold 3,562 Filana Therapeutics shares in Q3 2021, an estimated $304K.
- Panagora Asset Management first reported a position in Filana Therapeutics in Q1 2014 and held it in 14 quarters.
- Panagora Asset Management's Filana Therapeutics position peaked at $427K in Q2 2014.
- 180 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2021.
Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.